Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Lamictal (Lamotrigine) Tablets & Chewable Dispersible Tablets
Company: GlaxoSmithKline
Application No.:  020241s017 & 020764s011
Approval Date: 06/20/2003


Date created: May 29, 2007

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.